Edition:
United Kingdom

Profile: Idorsia Ltd (IDIA.S)

IDIA.S on Swiss Exchange

23.52CHF
19 Jul 2019
Change (% chg)

CHF0.40 (+1.73%)
Prev Close
CHF23.12
Open
CHF23.30
Day's High
CHF23.70
Day's Low
CHF23.22
Volume
270,994
Avg. Vol
294,831
52-wk High
CHF26.00
52-wk Low
CHF15.20

Idorsia Ltd is a Switzerland-based biopharmaceutical company, which specializes in the discovery and development of small molecules, to meet significant unmet medical needs. The Company will have a diverse clinical development pipeline comprising several compounds being investigated in multiple therapeutic areas, including central nervous system disorders, cardiovascular disorders, immunological disorders and orphan diseases. The Company's development compounds target a number of different diseases such as: Resistant Hypertension, Systemic lupus erythematosus, Chronic insomnia and Fabry disease, among others.

Company Address

Idorsia Ltd

Hegenheimermattweg 91
ALLSCHWIL     4123

Company Web Links